作者:
Mateos, Maria-Victoria [1]
;
Granell, Miguel [2]
;
Oriol, Albert [3]
;
Martinez-Lopez, Joaquin [4]
;
Blade, Joan [5]
;
Hernandez, Miguel T. [6]
;
Martin, Jesus [7]
;
Gironella, Mercedes [8]
;
Lynch, Mark [9]
;
Bleickardt, Eric [10]
;
Paliwal, Prashni [11]
;
Singhal, Anil [12]
;
San-Miguel, Jesus
作者单位:
Hosp Germans Trias, Inst Catala Oncol, Inst Josep Carreras, Badalona, Spain
[1]
Hosp Univ Virgen del Rocio, Dept Haematol, Seville, Spain
[2]
AbbVie Biotherapeut Inc ABR, Redwood City, CA USA
[3]
Complejo Hosp Univ Canarias, Santa Cruz De Tenerife, Spain
[4]
Complejo Asistencial Univ Salamanca, Dept Haematol, Inst Biosanitario Salamanca IBSAL, Salamanca
[5]
Bristol Myers Squibb, Oncol Clin Dev, Princeton, NJ USA
[6]
Hosp Univ Vall dHebron, Dept Haematol, Barcelona, Spain
[7]
Hosp Santa Creu & Sant Pau, Dept Haematol, Barcelona, Spain
[8]
Univ Complutense, Hosp Univ 12 Octubre, Sch Med, Haematol Dept,CNIO, Madrid, Spain
[9]
Hosp Clin Barcelona, Dept Haematol, IDIBAPS, Barcelona, Spain
[10]
Univ Navarra Clin, CIMA, IdiSNA Inst Invest Sanitaria Navarra, Clin & Translat Med, Pamplona, Spain
[11]
Bristol Myers Squibb, Global Regulatory Safety & Biometr, Princeton, NJ USA
[12]
发布时间
2017-04-06